DNTH: Dianthus Therapeutics O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Dianthus Therapeutics (DNTH) o'z laboratoriyalarida asosiy ekologik standartlarga rioya qiladi. PEG koeffitsiyenti joriy bozor dinamikasini aks ettiradi, bunda 0.00 joriy metrikani shakllantiradi. Istiqbollar DNTH103 molekulasining samaradorligi va naqd pul sarflash sur'atiga bog'liq. Biznesni rivojlantirish noyob genetik patologiyalarni davolashdagi muvaffaqiyatga va intellektual mulkni himoya qilishga asoslangan.
Dianthus Therapeutics (DNTH) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Dianthus Therapeutics|DNTH - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi dianthustx.com|DNTH - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Dianthus Pharma|DNTH - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzdorligi Dianthus Therapeutics|Oraliq qoplama koeffitsiyenti dianthustx.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
DNTH - Sof foyda|Prognoz qilingan kelajakdagi foyda Dianthus Therapeutics|DNTH - Narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati Dianthus Corp|DNTH - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti Dianthus Pharma|DNTH - EBITDA operatsion foydasi|Sirpanuvchi yil uchun bir aksiya uchun foyda Dianthus Therapeutics|DNTH - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi dianthustx.com|DNTH - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Dianthus Therapeutics
Kompaniyaning umumiy tahlili:DNTH - Dianthus Therapeutics Inc
Dianthus Therapeutics (DNTH) kompaniyasining komplement inhibitorlarini ishlab chiqishga yo'naltirilgan maxsus e'tibori R&D salohiyatini baholashni muhim qiladi. PEG fundamental ko'rsatkichi joriy P/E koeffitsientini foyda o'sish sur'atlari bilan solishtirib, bozor qiymati tibbiy nishalarga kelgusidagi kengayish bilan asoslangan yoki yo'qligini aniqlaydi. Ushbu grafikdagi birdan past qiymatlar aktivning o'sish sur'atlariga nisbatan past baholanganligini anglatadi va biznesning investitsiya jozibadorligini tasdiqlaydi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Pharvaris Corp - PEG multiplikatori|ABCL (AbCellera Biologics) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|TRML: PEG multiplikatori|PGEN - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PHAR (Pharming Group) - PEG multiplikatori|PEG multiplikatori Nektar Therapeutics Inc|Narxning foydaga va o‘sish sur’atiga nisbati Upstream Bio Corp (UPB)|Zenas Corp - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Immunome, Inc. - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati GOSS (gossamerbio.com)|KalVista Pharmaceuticals, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti SEPN (Septerna, Inc.)|PVLA (Pieris Pharmaceuticals Inc) - Narx-foyda va o‘sish multiplikatori|Savara Pharma (SVRA) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Rigel Pharmaceuticals|anaptysbio.com (ANAB) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori ATXS (Astria Therapeutics, Inc.)|ENGN (enGene Holdings Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|RAPT Therapeutics, Inc. - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati JBIO (Aerovate Therapeutics, Inc.)|Aclaris Therapeutics - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti KYTX (kyvernatx.com)|TLSA: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Cabaletta Bio Inc. (CABA)|Narxning foydaga va o‘sish sur’atiga nisbati Ventyx Bio|THTX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori AVTX|PEG multiplikatori eledon.com (ELDN)|Narxning foydaga va o‘sish sur’atiga nisbati Agenus Inc. AGEN|CLYM (Climb Bio Inc.) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Zura Bio Limited - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda aTyr Pharmaceuticals|ADAG (adagene.com) - Narx-foyda va o‘sish multiplikatori|Ikena Oncology (IMA) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori STTK|EQ (Equillium Bio) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori CNTB|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati immunic-therapeutics.com|PEG multiplikatori ATRA (Atara Bio)|IFRX - Narx-foyda va o‘sish multiplikatori|XFOR - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Adicet Bio ACET|CELU: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti INMB|Narxning foydaga va o‘sish sur’atiga nisbati Barinthus Biotherapeutics|O‘sishni hisobga olgan narx-foyda koeffitsiyenti KZR (kezarlifesciences.com)|Narx-foyda va o‘sish multiplikatori SABS (SAB Biotherapeutics, Inc.)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati AKTX|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti QTTB|GOVX - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati EDSA|IBIO: PEG multiplikatori|Carisma Therapeutics Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|XTLB (XTL Biopharmaceuticals, Ltd.) - PEG multiplikatori|PEG multiplikatori Bolt Bio|Narxning foydaga va o‘sish sur’atiga nisbati HCW Biologics Inc. (HCWB)|APVO (aptevotherapeutics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati AIM ImmunoTech AIM|ADTX - Narx-foyda va o‘sish multiplikatori|GRI Bio Corp - PEG multiplikatori|XRTX - PEG multiplikatori|HIND (Vyome Holdings Inc) - Narx-foyda va o‘sish multiplikatori|revbiosciences.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|INDP (Indaptus Therapeutics, Inc.) - PEG multiplikatori|Scinai Immunotherapeutics Ltd (SCNI) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati CalciMedica, Inc. (CALI)|Narx-foyda va o‘sish multiplikatori affimed.com AFMD|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK - Narx-foyda va o‘sish multiplikatori|IGMS: Narx-foyda va o‘sish multiplikatori|ITOS - PEG multiplikatori|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TCBP|THRD (Third Harmonic Bio) - PEG multiplikatori
